The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.

Say goodbye to the classic ClinicalTrials.gov!

The classic ClinicalTrials.gov website will be retired on June 25, 2024. Please use the modernized ClinicalTrials.gov. For more information, see ClinicalTrials.gov Modernization.

Key Record Dates

ClinicalTrials.gov Identifier:	NCT02650401
Brief Title:	Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options (STARTRK-NG)

First Submitted :	January 4, 2016
First Submitted that Met QC Criteria :	January 7, 2016
First Posted :	January 8, 2016 (Estimate)

Last Update Submitted that Met QC Criteria :	March 28, 2024
Last Update Posted :	March 29, 2024

To Top